Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-77c89778f8-9q27g Total loading time: 0 Render date: 2024-07-18T06:32:56.494Z Has data issue: false hasContentIssue false

53 - Anticholinergics in the Treatment of Dystonia

from Section VII - Pharmacotherapy for Dystonia

Published online by Cambridge University Press:  31 May 2018

By
Michel Sáenz-Farret  and
Federico Micheli
Edited by
Dirk Dressler ,
Eckart Altenmüller  and
Joachim K. Krauss
Dirk Dressler
Affiliation:
Hannover Medical School
Eckart Altenmüller
Affiliation:
Hochschule für Musik, Theater und Medien, Hannover
Joachim K. Krauss
Affiliation:
Hannover Medical School
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Treatment of Dystonia , pp. 268 - 271
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Albright, AL (1996) Spasticity and movement disorders in cerebral palsy. J Child Neurol 11(Suppl. 1), S1–4.Google Scholar
Battini, R, Casarano, M, Sgandurra, G, Olivieri, I, Di Pietro, R, Romeo, DM, Mercuri, E, Cioni, G (2014) Responsiveness of the MD-childhood rating scale in dyskinetic cerebral palsy patients undergoing anticholinergic treatment. Eur J Paediatr Neurol 18, 698–703.CrossRefGoogle ScholarPubMed
Ben-Pazi, H (2011) Trihexyphenidyl improves motor function in children with dystonic cerebral palsy: a retrospective analysis. J Child Neurol 26, 810–816.CrossRefGoogle ScholarPubMed
Brans, JW, Lindeboom, R, Snoek, JW, Zwarts, MJ, van Weerden, TW, Brunt, ER, van Hilten, JJ, van der Kamp, W, Prins, MH, Speelman, JD (1996) Botulinum toxin versus trihexyphenidyl in cervical dystonia: a prospective, randomized, double-blind controlled trial. Neurology 46, 1066–1072.Google Scholar
Burke, RE, Fahn, S, Marsden, CD (1986) Torsion dystonia: a double-blind, prospective trial of high-dosage trihexyphenidyl. Neurology 36, 160–164.Google Scholar
Carranza-del Rio, J, Clegg, NJ, Moore, A, Delgado, MR (2011) Use of trihexyphenidyl in children with cerebral palsy. Pediatr Neurol 44, 202–206.CrossRefGoogle ScholarPubMed
Chuang, C, Fahn, S, Frucht, SJ (2002) The natural history and treatment of acquired hemidystonia: report of 33 cases and review of the literature. J Neurol Neurosurg Psychiatry 72, 59–67.CrossRefGoogle ScholarPubMed
Deuschl, G (2003) Dystonic tremor. Rev Neurol (Paris) 159, 900–905.Google ScholarPubMed
Eskow Jaunarajs, KL, Bonsi, P, Chesselet, MF, Standaert, DG, Pisani, A (2015) Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia. Prog Neurobiol 127–128C, 91–107.CrossRefGoogle ScholarPubMed
Fahn, S (1983) High dosage anticholinergic therapy in dystonia. Neurology 33, 1255–1261.CrossRefGoogle ScholarPubMed
Fasano, A, Bove, F, Lang, AE (2014) The treatment of dystonic tremor: a systematic review. J Neurol Neurosurg Psychiatry 85, 759–769.CrossRefGoogle ScholarPubMed
Granana, N, Ferrea, M, Scorticati, MC, Diaz, S, Arrebola, M, Torres, L, Micheli, F (1999) Beneficial effects of diphenhydramine in dystonia. Medicina (B Aires) 59, 38–42.Google ScholarPubMed
Greene, P, Shale, H, Fahn, S (1988) Analysis of open-label trials in torsion dystonia using high dosages of anticholinergics and other drugs. Mov Disord 3, 46–60.CrossRefGoogle ScholarPubMed
Hoon, AH, Jr, Freese, PO, Reinhardt, EM, Wilson, MA, Lawrie, WT, Jr, Harryman, SE, Pidcock, FS, Johnston, MV (2001) Age-dependent effects of trihexyphenidyl in extrapyramidal cerebral palsy. Pediatr Neurol 25, 55–58.CrossRefGoogle ScholarPubMed
Hughes, AJ, Lees, AJ, Marsden, CD (1991) Paroxysmal dystonic head tremor. Mov Disord 6, 85–86.CrossRefGoogle ScholarPubMed
Jankovic, J (2013) Medical treatment of dystonia. Mov Disord 28, 1001–1012.CrossRefGoogle ScholarPubMed
Kostic, V, Przedborski, S, Jackson-Lewis, V, Cadet, JL, Burke, RE (1991) Effect of unilateral perinatal hypoxic-ischemic brain injury in the rat on striatal muscarinic cholinergic receptors and high-affinity choline uptake sites: a quantitative autoradiographic study. J Neurochem 57, 1962–1970.Google Scholar
Lang, AE (1986) High dose anticholinergic therapy in adult dystonia. Can J Neurol Sci 13, 42–46.CrossRefGoogle ScholarPubMed
Maltese, M, Martella, G, Madeo, G, Fagiolo, I, Tassone, A, Ponterio, G, Sciamanna, G, Burbaud, P, Conn, PJ, Bonsi, P, Pisani, A (2014). Anticholinergic drugs rescue synaptic plasticity in DYT1 dystonia: role of M1 muscarinic receptors. Mov Disord 29, 1655–1665.CrossRefGoogle ScholarPubMed
Martella, G, Tassone, A, Sciamanna, G, Platania, P, Cuomo, D, Viscomi, MT, Bonsi, P, Cacci, E, Biagioni, S, Usiello, A, Bernardi, G, Sharma, N, Standaert, DG, Pisani, A (2009) Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine. Brain 132, 2336–2349.Google Scholar
Oztekin, NS, Saygi, SS, Dalkara, T, Senses, I, Zileli, T (1991) High dose anticholinergic therapy (biperiden) in dystonia. Clin Neurol Neurosurg 93, 35–37.Google Scholar
Pettigrew, LC, Jankovic, J (1985) Hemidystonia: a report of 22 patients and a review of the literature. J Neurol Neurosurg Psychiatry 48, 650–657.CrossRefGoogle Scholar
Pidcock, FS, Hoon, AH, Jr, Johnston, MV (1999) Trihexyphenidyl in posthemorrhagic dystonia: motor and language effects. Pediatr Neurol 20, 219–222.CrossRefGoogle ScholarPubMed
Pisani, A, Bernardi, G, Ding, J, Surmeier, DJ (2007) Re-emergence of striatal cholinergic interneurons in movement disorders. Trends Neurosci 30, 545–553.Google Scholar
Poewe, W, Lees, AJ, Steiger, D, Stern, GM (1987) Foot dystonia in Parkinson’s disease: clinical phenomenology and neuropharmacology. Adv Neurol 45, 357–360.Google Scholar
Poewe, WH, Lees, AJ, Stern, GM (1988) Dystonia in Parkinson’s disease: clinical and pharmacological features. Ann Neurol 23, 73–78.CrossRefGoogle ScholarPubMed
Povlsen, UJ, Pakkenberg, H (1990) Effect of intravenous injection of biperiden and clonazepam in dystonia. Mov Disord 5, 27–31.Google Scholar
Rice, J, Waugh, MC (2009) Pilot study on trihexyphenidyl in the treatment of dystonia in children with cerebral palsy. J Child Neurol 24, 176–182.Google Scholar
Robottom, BJ, Reich, SG (2011) Exposure to high dosage trihexyphenidyl during pregnancy for treatment of generalized dystonia: case report and literature review. Neurologist 17, 340–341.CrossRefGoogle ScholarPubMed
Rosenbaum, F, Jankovic, J (1988) Focal task-specific tremor and dystonia: categorization of occupational movement disorders. Neurology 38, 522–527.CrossRefGoogle ScholarPubMed
Sanger, TD, Bastian, A, Brunstrom, J, Damiano, D, Delgado, M, Dure, L, Gaebler-Spira, D, Hoon, A, Mink, JW, Sherman-Levine, S, Welty, LJ, Child Motor Study Group (2007) Prospective open-label clinical trial of trihexyphenidyl in children with secondary dystonia due to cerebral palsy. J Child Neurol 22, 530–537.CrossRefGoogle ScholarPubMed
Schneider, SA, Bhatia, KP (2007) The entity of jaw tremor and dystonia. Mov Disord 22, 1491–1495.Google Scholar
Taylor, AE, Lang, AE, Saint-Cyr, JA, Riley, DE, Ranawaya, R (1991) Cognitive processes in idiopathic dystonia treated with high-dose anticholinergic therapy: implications for treatment strategies. Clin Neuropharmacol 14, 62–77.Google Scholar
Thenganatt, MA, Jankovic, J (2014) Treatment of dystonia. Neurotherapeutics 11, 139–152.CrossRefGoogle ScholarPubMed
Truong, DD, Sandroni, P, van den Noort, S, Matsumoto, RR (1995). Diphenhydramine is effective in the treatment of idiopathic dystonia. Arch Neurol 52, 405–407.CrossRefGoogle ScholarPubMed
Van der Burg, JJ, Jongerius, PH, Van Hulst, K, Van Limbeek, J, Rotteveel, JJ (2006) Drooling in children with cerebral palsy: effect of salivary flow reduction on daily life and care. Dev Med Child Neurol 48, 103–107.CrossRefGoogle ScholarPubMed
van’t Groenewout, JL, Stone, MR, Vo, VN, Truong, DD, Matsumoto, RR (1995) Evidence for the involvement of histamine in the antidystonic effects of diphenhydramine. Exp Neurol 134, 253–260.CrossRefGoogle ScholarPubMed
Vidailhet, M (2013) Treatment of movement disorders in dystonia-choreoathtosis cerebral palsy. Handb Clin Neurol 111, 197–202.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×